Nighthawk Biosciences Inc

NHWK
0,4135
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202422:00EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
03/5/202413:18EDGAR2Form S-1 - General form for registration of securities under..
02/5/202414:00EDGAR2Form 8-K - Current report
30/4/202414:00EDGAR2Form 8-K - Current report
29/4/202414:10EDGAR2Form 8-K - Current report
22/4/202423:00EDGAR2Form 8-K - Current report
01/4/202422:52EDGAR2Form NT 10-K - Notification of inability to timely file Form..
19/3/202413:30GLOBEScorpius Holdings Awarded Contract in Excess of $1 Million..
14/3/202413:30GLOBEScorpius Holdings Accepted as a Member of the US..
13/3/202411:17EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
13/3/202411:01EDGAR2Form 8-K - Current report
12/3/202422:00GLOBEScorpius Holdings, Inc. Announces Closing of Public Offering
08/3/202406:20GLOBEScorpius Holdings, Inc. Announces Pricing of Public Offering
07/3/202422:18GLOBEScorpius Holdings, Inc. Announces Proposed Public Offering..
07/3/202414:30GLOBEScorpius Holdings Estimates Greater than 375% Sequential..
06/2/202415:34EDGAR2Form 8-K - Current report
06/2/202414:00GLOBENightHawk Biosciences Completes Name Change to Scorpius..
01/2/202414:00GLOBENightHawk’s Scorpius BioManufacturing Subsidiary Announces..
30/1/202414:00EDGAR2Form 8-K - Current report
30/1/202414:00GLOBENightHawk Receives Proceeds of $3.25 Million in Connection..
26/1/202422:30EDGAR2Form 8-K - Current report
25/1/202414:30GLOBENightHawk’s Scorpius BioManufacturing Subsidiary Awarded..
22/1/202414:00EDGAR2Form 8-K - Current report
16/1/202414:30EDGAR2Form 8-K - Current report
16/1/202414:30GLOBENightHawk’s Scorpius BioManufacturing Subsidiary Commences..
11/1/202422:59EDGAR2Form 8-K - Current report
08/1/202414:30EDGAR2Form 8-K - Current report
08/1/202414:30GLOBENightHawk Biosciences Announces Planned Name Change to..
03/1/202414:30GLOBENightHawk Biosciences Commences Work on Multi-Million-Dollar..
27/12/202322:57EDGAR2Form 8-K - Current report
21/12/202314:30GLOBENightHawk Biosciences Announces Completion of Demonstration..
19/12/202322:47EDGAR2Form S-3 - Registration statement under Securities Act of..
19/12/202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202322:05EDGAR2Form 8-K - Current report
18/12/202314:30GLOBENightHawk Biosciences Announces Major Milestone with..
12/12/202322:03EDGAR2Form 8-K - Current report
12/12/202314:30GLOBENightHawk Biosciences Announces Strategic Shift into a..
08/12/202322:31EDGAR2Form 8-K - Current report
08/12/202322:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/11/202322:05GLOBENightHawk Biosciences Provides Q3 2023 Business Update
14/8/202322:05GLOBENightHawk Biosciences Provides Q2 2023 Business Update
15/5/202322:05GLOBENightHawk Biosciences Provides Q1 2023 Business Update
Apertura: Min: Max:
Chiusura: 0,4135

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network